Company: CHNR
Filing Date: 2025-05-15
Form Type: 424B5
Source: 0001079973-25-000830
Chunk: 32

Company: CHINA NATURAL RESOURCES INC
Filing Date: 2025-05-15
Form: 424B5
Chunk 32
---
 the table below (as such table may be amended from time to time by means of
an amendment to the registration statement of which this prospectus forms a part or by a supplement to this prospectus) and (ii) any donees,
pledgees, transferees or other successors-in-interest that acquire any of the Resale Securities covered by this prospectus after the date
of this prospectus from the named Selling Shareholders as a gift, pledge, partnership distribution or other non-sale related transfer.

Certain of the Selling Shareholders have purchased
their respective Common Shares at prices lower than current market prices and may therefore experience a positive rate of return on their
investment, even if our public shareholders experience a negative rate of return on their investment. As a result, the Selling Shareholders
are able to recognize a greater return on their investment than shareholder or holders of Warrants acquired in the public market. Furthermore,
the Selling Shareholders may earn a positive rate of return even if the price of the Ordinary Shares declines significantly. As a result,
the Selling Shareholders may be willing to sell their shares at a price less than shareholders that acquired their Common Shares in the
public market or at higher prices than the price paid by such Selling Shareholders, the sale of which would result in the Selling Shareholder
realizing a significant gain even if other CHNR shareholders experience a negative rate of return.

The sale or possibility of sale of the Common Shares,
including those pursuant to this prospectus supplement, could have the effect of increasing the volatility in Common Share price or putting
significant downward pressure on the price of Common Shares. The Common Shares being offered for resale by the Selling Shareholders pursuant
to this prospectus supplement represent approximately 10.77% of our total issued and outstanding Common Shares on a fully diluted basis
(assuming and after giving effect to the issuance of 1,190,297 Common Shares upon exercise of all outstanding warrants).

The table below sets forth, as of the date of this
prospectus supplement, the name of the Selling Shareholders for which we are registering Resale Securities for resale to the public, and
the aggregate principal amount that the Selling Shareholders may offer pursuant to this prospectus supplement. In accordance with SEC
rules, individuals and entities below are shown as having beneficial ownership over securities they own or have the right to acquire within
60 days, as well as securities for which they have the right to vote or dispose of such securities. Also, in accordance with SEC rules,
for purposes